AIS
NVS icon

Advocate Investing Services’s Novartis NVS Stock Holding History

Advocate Investing Services’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35K Hold
15
– – ﹤0.01% 376
2026
Q1 		$2.29K Hold
15
– – ﹤0.01% 358
2025
Q4 		$2.07K Buy
+15
New +$1.96K ﹤0.01% 339

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Advocate Investing Services's NVS Position: Q2 2026 in Review

Advocate Investing Services held its Novartis (NVS) position steady in Q2 2026 at 15 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Advocate Investing Services first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Advocate Investing Services held 15 shares of Novartis worth $2.35K as of Q2 2026.
  • Advocate Investing Services left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Advocate Investing Services's portfolio in Q2 2026, its #376 holding.
  • Advocate Investing Services first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Advocate Investing Services's 13F filing for Q2 2026, filed 29 Jul 2026.